Lamictal XR 250 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F71QW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,784
Award facts
- Contract value 100% obligated
- $6,783.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,783.85 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 250 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was executed on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries with the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent IDC facilitates AmerisourceBergen's supply of pharmaceutical products to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key strategic partner in the DLA's Pharmaceutical Prime Vendor Global Program, which is expected to make multiple regional awards among several contractors.
Quick answers
Who was awarded contract SPE2DR26F71QW?
SPE2DR26F71QW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DR26F71QW worth?
The government has obligated $6,784 on SPE2DR26F71QW.
Is contract SPE2DR26F71QW an order under another contract?
Yes. SPE2DR26F71QW is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F71QW competed?
The extent of competition for SPE2DR26F71QW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award